FTC Sues Omnicare To Block $441M PharMerica Merger

Law360, New York (January 27, 2012, 8:06 PM EST) -- U.S. antitrust regulators on Friday moved to block Omnicare Inc.’s proposed $440.8 million deal for PharMerica Corp. over concerns that a merger of the country’s two largest long-term care pharmacies would raise drug prices, particularly for Medicare patients, and hurt competition.

The U.S. Federal Trade Commission filed an administrative lawsuit to stop the merger, claiming it would give Covington, Ky.-based Omnicare more than half of the U.S. market for pharmacy services at nursing homes and other long-term facilities, where patients receive prescription drugs from sponsors of...
To view the full article, register now.